Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy
Shanshan Sun, Yu Feng, Danying Xu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188700-188700
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Epigenetic regulation and therapeutic targets in the tumor microenvironment
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 21
Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
Linlin Zhou, Danny Yu
Pharmacological Research (2024) Vol. 204, pp. 107205-107205
Open Access | Times Cited: 13
EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer
Y. Chen, Hongyan Zhu, Yi Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116624-116624
Open Access | Times Cited: 8
Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer
Yafang Wang, Yu Lei, Zong-long Hu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 33
Valemetostat Tosilate: First Approval
Susan J. Keam
Drugs (2022) Vol. 82, Iss. 16, pp. 1621-1627
Open Access | Times Cited: 28
EZH2: An Accomplice of Gastric Cancer
Wuhan Yu, Ning Liu, Xiaogang Song, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 425-425
Open Access | Times Cited: 19
Integrated analyses of prognostic and immunotherapeutic significance of EZH2 in uveal melanoma
Junfang Li, Yifei Zhang, Yang Qiu, et al.
Methods (2025) Vol. 234, pp. 242-252
Closed Access
Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access
Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation
Rihua He, Chonghui Hu, Yuan Yuan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Exploring manzamine a: a promising anti-lung cancer agent from marine sponge Haliclona sp
Su Min, Jie Zhu, Lu Bai, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The epigenetic hallmarks of immune cells in cancer
Ji Yu, Chu Xiao, Tao Fan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies
Ivana Samaržija, Marko Tomljanović, Renata Novak Kujundžić, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4761-4761
Open Access | Times Cited: 22
Exosomes‐mediated crosstalk between glioma and immune cells in the tumor microenvironment
Xu Guo, Rui Sui, Haozhe Piao
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2074-2085
Open Access | Times Cited: 13
The pharmacological and biological importance of EZH2 signaling in lung cancer
Maliheh Entezari, Afshin Taheriazam, Mahshid Deldar Abad Paskeh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114313-114313
Open Access | Times Cited: 12
Sunitinib attenuates reactive MDSCs enhancing anti-tumor immunity in HNSCC
Jie Liu, Wen‐Ping Lin, Wen Su, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110243-110243
Closed Access | Times Cited: 11
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells
Xinyu Tian, Ting Wang, Han Shen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 108-121
Closed Access | Times Cited: 11
YAP represses intestinal inflammation through epigenetic silencing of JMJD3
Hua Zhu, Jiali Lu, Ming‐Yue Fu, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
EZH2-Myc Hallmark in Oncovirus/Cytomegalovirus Infections and Cytomegalovirus’ Resemblance to Oncoviruses
Ranim El Baba, Georges Herbein
Cells (2024) Vol. 13, Iss. 6, pp. 541-541
Open Access | Times Cited: 3
EZH2‐associated tumor malignancy: A prominent target for cancer treatment
Maryam Sabour Takanlou, Leila Sabour Takanlou, Çiğir Biray-Avci
Clinical Genetics (2024) Vol. 106, Iss. 4, pp. 377-385
Open Access | Times Cited: 3
Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis
Qing-Ming Wang, Guang‐Yu Lian, Su-Mei Sheng, et al.
Molecular Cancer Research (2023) Vol. 22, Iss. 2, pp. 125-136
Closed Access | Times Cited: 9
Implications in Cancer of Nuclear Micro RNAs, Long Non-Coding RNAs, and Circular RNAs Bound by PRC2 and FUS
Guruprasadh Swaminathan, Diana G. Rogel-Ayala, Amine Armich, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 868-868
Open Access | Times Cited: 2
lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
Michał Woźniak, Małgorzata Czyż
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 6
High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
Zhitao Chen, Xin Lin, Zhenmiao Wan, et al.
Genes (2022) Vol. 13, Iss. 5, pp. 876-876
Open Access | Times Cited: 10
Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth and Lung Metastasis in a Triple Negative Breast Cancer Model
Lenore Monterroza, Maria M. Parrilla, Sarah G. Samaranayake, et al.
(2024)
Open Access | Times Cited: 1
Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model
Lenore Monterroza, Maria M. Parrilla, Sarah G. Samaranayake, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5392-5392
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top